Search research articles
Contact Us
Filters
Showing results (161-170 of 227) with videos related to
Page
of 23
Sort By:
Cancer
|
September 29, 2024
Southwest Oncology Group S0826: A phase 2 trial of SCH 727965 (NSC 727135, dinaciclib) in patients with stage IV melanoma
Christopher D Lao, James Moon, Vincent T Ma, et al.
Journal of Neuro-Oncology
|
August 31, 2012
Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme
Kenneth F Grossmann, Howard Colman, Wallace A Akerley, et al.
Biorxiv : the Preprint Server for Biology
|
November 28, 2023
Oxidation of hemoglobin in the lung parenchyma facilitates the differentiation of pneumococci into encapsulated bacteria
Babek Alibayov, Anna Scasny, Ana G Jop Vidal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2011
Randomized phase II study of erlotinib plus tivantinib versus erlotinib plus placebo in previously treated non-small-cell lung cancer
Lecia V Sequist, Joachim von Pawel, Edward G Garmey, et al.
Omics : a Journal of Integrative Biology
|
April 27, 2004
In Silico Metabolic Model and Protein Expression of Haemophilus influenzae Strain Rd KW20 in Rich Medium
Anu Raghunathan, Nathan D Price, Michael Y Galperin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 26, 2023
Phase II Study of Docetaxel and Trametinib in Patients with KRAS Mutation Positive Recurrent Non-Small Cell Lung Cancer (NSCLC; SWOG S1507, NCT-02642042)
Shirish M Gadgeel, Jieling Miao, Jonathan W Riess, et al.
Frontiers in Oncology
|
January 25, 2021
MYBL2-Driven Transcriptional Programs Link Replication Stress and Error-prone DNA Repair With Genomic Instability in Lung Adenocarcinoma
Benjamin B Morris, Nolan A Wages, Patrick A Grant, et al.
Journal of the National Cancer Institute
|
July 22, 2021
Cancer Misinformation and Harmful Information on Facebook and Other Social Media: A Brief Report
Skyler B Johnson, Matthew Parsons, Tanya Dorff, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 11, 2015
NCCN Oncology Research Program's Investigator Steering Committee and NCCN Best Practices Committee Molecular Profiling Surveys
Razelle Kurzrock, A Dimitrios Colevas, Anthony Olszanski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 27, 2016
Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer
Martin Reck, Alexander Luft, Aleksandra Szczesna, et al.
Page
of 23
Search research articles
Search
Showing results (161-170 of 227) with videos related to
Sort By:
Page
of 23
Cancer
|
September 29, 2024
Southwest Oncology Group S0826: A phase 2 trial of SCH 727965 (NSC 727135, dinaciclib) in patients with stage IV melanoma
Christopher D Lao, James Moon, Vincent T Ma, et al.
Journal of Neuro-Oncology
|
August 31, 2012
Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme
Kenneth F Grossmann, Howard Colman, Wallace A Akerley, et al.
Biorxiv : the Preprint Server for Biology
|
November 28, 2023
Oxidation of hemoglobin in the lung parenchyma facilitates the differentiation of pneumococci into encapsulated bacteria
Babek Alibayov, Anna Scasny, Ana G Jop Vidal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2011
Randomized phase II study of erlotinib plus tivantinib versus erlotinib plus placebo in previously treated non-small-cell lung cancer
Lecia V Sequist, Joachim von Pawel, Edward G Garmey, et al.
Omics : a Journal of Integrative Biology
|
April 27, 2004
In Silico Metabolic Model and Protein Expression of Haemophilus influenzae Strain Rd KW20 in Rich Medium
Anu Raghunathan, Nathan D Price, Michael Y Galperin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 26, 2023
Phase II Study of Docetaxel and Trametinib in Patients with KRAS Mutation Positive Recurrent Non-Small Cell Lung Cancer (NSCLC; SWOG S1507, NCT-02642042)
Shirish M Gadgeel, Jieling Miao, Jonathan W Riess, et al.
Frontiers in Oncology
|
January 25, 2021
MYBL2-Driven Transcriptional Programs Link Replication Stress and Error-prone DNA Repair With Genomic Instability in Lung Adenocarcinoma
Benjamin B Morris, Nolan A Wages, Patrick A Grant, et al.
Journal of the National Cancer Institute
|
July 22, 2021
Cancer Misinformation and Harmful Information on Facebook and Other Social Media: A Brief Report
Skyler B Johnson, Matthew Parsons, Tanya Dorff, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 11, 2015
NCCN Oncology Research Program's Investigator Steering Committee and NCCN Best Practices Committee Molecular Profiling Surveys
Razelle Kurzrock, A Dimitrios Colevas, Anthony Olszanski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 27, 2016
Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer
Martin Reck, Alexander Luft, Aleksandra Szczesna, et al.
Page
of 23